Business Wire

CA-FAUNA

7.7.2021 15:02:05 CEST | Business Wire | Press release

Share
With Global Demand Growing, Fauna Launches New Region Groups, Achieves SOC 2 Compliance, and Adds Sales Leader to Further Accelerate Company Momentum

Fauna , the data API for modern applications, today announced the availability of a new US and European Region Groups and attainment of SOC 2 compliance to support the data residency and regulatory compliance needs of customers. The company also announced the addition of new sales leadership with deep developer and enterprise sales experience. The combination of these new features and sales leadership will help accelerate customer adoption of Fauna globally.

Thus far in 2021 Fauna has experienced 200+% growth in new customers in over 50 countries around the globe. Leveraging Fauna, these companies are bringing disruptive new applications to market more quickly by leaning heavily on the developer productivity that Fauna brings to the table, as well as by foregoing the need to care for and feed traditional database infrastructure.

“As our customer base has grown globally and larger organizations have begun adopting Fauna, it is critical for us to provide additional levels of compliance and more fine grained ways in which customers can manage their data residency needs within Fauna,” said Eric Berg, CEO of Fauna. “The combination of SOC2 compliance and our new Region Groups architecture allows us to meet those needs while still delivering a great developer experience and the zero database operations approach our customers love. Matt Slagle’s addition to the team to scale sales and build out a vibrant partner ecosystem also adds the right leadership and focus to accelerate our business by ensuring customers globally are successful with Fauna.”

New Geographic Region Groups

Unique to Fauna, its new Region Group capability allows global brands to meet local data residency requirements without compromising the performance, latency and reliability gained from distributing data across multiple cloud regions across a geography. Moreover, Region Groups control has been added to the zero operations experience that customers love about Fauna - no database operations required.

Countries around the world have introduced data sovereignty and privacy laws such as the GDPR that require companies to keep application data within the same area from which it was generated. However, to make applications more performant, and resilient, companies also want to bring data closer to their users across multiple cloud regions.

“App developers want to focus on building the app, not worrying about regional and international regulations and restrictions, or building high availability and redundancy services across modern distributed infrastructures,” said James Governor, co-founder of Redmonk. “Making control of data residency easy in specific geographical regions will make life much easier for developers.”

Fauna’s new capabilities address these requirements by enabling companies to pin their databases to a specific geographic area, called a Region Group. Within each Region Group, Fauna automatically distributes and scales these databases across multiple cloud regions within that area to minimize query latency while ensuring data resiliency. All of this is done without any operational overhead for a Fauna customer, continuing to deliver on our zero database operations promise.

Customers have the flexibility to mix and match Region Groups and create databases where the business demands. Developers can start locally within a single Region Group, and add new databases in additional geographic areas as their customer base grows globally.

“Fauna’s new Region Groups break new ground in how and where data is stored and scaled, which has a major impact on performance and data privacy,” said Hassen Karaa, Vice President of Product for Fauna. “We’ve put the right data infrastructure in place in each geographic region to meet our growing customer needs. Moreover, we manage it transparently so that our customers can focus on building applications that scale and comply with their data privacy local regulations and laws.”

SOC 2 Compliance

Data security, availability, confidentiality and reliability are critical considerations for businesses using public cloud infrastructure and SaaS vendors. As a cloud-native API Fauna was built with these in mind.

To demonstrate commitment to these principles Fauna chose the AICPA SOC2 framework of controls and is now SOC 2 Type 1 compliant. Fauna's service commitments and system requirements were achieved based on the trust services criteria relevant to security, availability, and confidentiality. A Type 1 report is available under NDA.

“As we continue to grow our services rapidly across the world, complying with local privacy regulations and data security is essential to our expansion, especially since we work with governments,” said Felix Engelhardt, Lead Engineer at EIDU. “Our use of Fauna has significantly accelerated our ability to bring ideas to market, and the new features being introduced today are critical to support our growth. We applaud Fauna’s innovation and responsiveness to our needs for compliance.”

New Sales Leadership to Drive Customer Success

As part of the company’s efforts to accelerate customer success, Fauna has hired Matt Slagle as its new Vice President of Sales. Slagle joins Fauna from New Relic, where he helped grow the company from less than 100 employees and under $10M in revenue to 2200 employees and ~$700M ARR. In his most recent role he was a Group Vice President of Sales managing a 140 person team that generated $100M+ in revenue.

“I joined Fauna because I recognized the company’s potential to be a major force in data management and app development via a developer focused go to market,” said Slagle. “Customers today love the developer experience and zero database operations that Fauna delivers and I am excited to join the team and help accelerate the focus on customer success.”

About Fauna

Fauna is the data API for modern applications. With Fauna, developers can simplify code, reduce costs, and ship applications faster by replacing their database infrastructure with a highly productive and programmable data API that combines the power of custom business logic with the ease of GraphQL. The underlying globally distributed storage and compute engine is fast, consistent, and reliable, with a modern security infrastructure. Itself a serverless offering, Fauna is quick to get started with and lets developers experience freedom from database operations at any scale. Innovators like Hannon Hill, ShiftX, DigitalAX, and MeetKai trust Fauna to power their applications. Backed by premier venture investors Madrona Venture Group, ADDITION, GV, and CRV, Fauna is headquartered in San Francisco with an experienced leadership team hailing from Microsoft, Okta, Amazon, New Relic, Twitter and Oracle. For more information visit fauna.com or follow us at @fauna.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye